Safety and Efficacy of Autologous RNA Chimeric Antigen Receptor T-cell (rCAR-T) Therapy in Myasthenia Gravis: a prospective, multicenter, open-label, non-randomised phase 1b/2a study

Saved in:

Bibliographic Details
Published in:	Lancet neurology Vol. 22; no. 7; pp. 578 - 590
Main Authors:	Granit, Volkan, Benatar, Michael, Kurtoglu, Metin, Miljković, Miloš D., Chahin, Nizar, Sahagian, Gregory, Feinberg, Marc H., Slansky, Adam, Vu, Tuan, Jewell, Christopher M., Singer, Michael S., Kalayoglu, Murat V., Howard, James F., Mozaffar, Tahseen
Format:	Journal Article
Language:	English
Published:	01-07-2023
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	Both first authors contributed to the work equally. All authors had full access to the study design information and all data in the study, reviewed, edited, and provided final approval of the manuscript content, and had final responsibility for the decision to submit for publication. Study design: VG, MB, MK, MSS, MVK, TM. Investigation and data collection: VG, NC, GS, MHF, AS, TV, JFH, TM. Data analysis: MDM. Data verification: MK, JFH. Data interpretation: VG, MB, CJ, MSS, JFH, TM. Writing — original draft: VG, MDM. Both senior authors contributed to the work equally. Contributors statement
ISSN:	1474-4422 1474-4465
DOI:	10.1016/S1474-4422(23)00194-1